Network analysis using Cytoscape has identified PTGS2, PTGS1, NCOA2, ADRB2, SCN5A, RXRA, NCOA1, ESR1, AR, and DPP4 as key targets for the treatment of CHD with BYXD. The gene discussed is RXRA; the disease is coronary artery disorder.